|
|
|
New Drug approvals expected in the future
Drug master files (DMFs) are submissions made to the FDA by manufacturers. DMF filings also help provide insights into some of the new drug approvals that can be expected in the future. Clearsynth is a technology based, research driven enterprise and leading service provider in the pharmaceutical industry committed to turning your ideas into success. Our goal is to offer you the best individually tailored solution for your project and needs and we are pleased to offer more new potential tool compounds which will help in your research.
|
|
Dyphylline D5CAT No. CS-O-36869 CAS No. NA |
|
|
|
Antazoline Phosphate D4CAT No. CS-O-36867 CAS No. 154-68-7 (Unlabelled) |
|
|
|
Bexagliflozin D2CAT No. CS-O-36864 CAS No. 1204221-72-6 |
|
|
|
Roxadustat D5CAT No. CS-O-35166 CAS No. 808118-40-3(Unlabeled) |
|
|
|
Treosulfan D4CAT No. CS-CX-00620 CAS No. 299-75-2 (Unlabeled) |
|
|
|
Omidenepag Isopropyl D7CAT No. CS-O-36863 CAS No. 1187451-19-9 (Unlabelled) |
|
|
|
Resiniferatoxin D3CAT No. CS-O-36829 CAS No. |
|
|
|
Indoximod D3CAT No. CS-O-36826 CAS No. 2281803-44-7 |
|
|
|
Fasoracetam D10CAT No. CS-O-36825 CAS No. 110958-19-5 (Unlabelled) |
|
|
|
Dapoxetine D6 hydrochlorideCAT No. CS-O-02692 CAS No. 1246814-76-5 |
Clearsynth Advantage
|
CUSTOMER SATISFACTIONAt Clearsynth we design the customer experience. |
100% MONEY BACKAll orders are facilitated with the utmost care and responsibility. |
PURCHASE PROTECTIONWith Clearsynth, you can be rest assured your purchase will be protected. |
Experienced R&D Team
|
Our focus is on success at each stage of development. Our efforts focus from the preclinical stage through to phase III and to the successful technology transfer to manufacturing locations throughout the world.
|
|
The 'Catalyst' in making your research work
Follow us
For more details visit us at www.clearsynth.com or call +91-22-45045900